Prediction of recurrence risk in patients with non-muscle-invasive bladder cancer

被引:0
作者
Ahmadi, Niloufar [1 ]
Shafee, Hamid [1 ]
Moudi, Emaduddin [2 ]
机构
[1] Babol Univ Med Sci, Dept Urol, Sch Med, Babol, Iran
[2] Babol Univ Med Sci, Hlth Res Inst, Canc Res Ctr, Dept Surg, Babol, Iran
关键词
Bladder cancer; Non-muscle-invasive; Recurrence; Prediction; NATURAL-HISTORY; TRANSURETHRAL RESECTION; TUMOR RECURRENCE; YOUNG-ADULTS; PROGRESSION; DIAGNOSIS; ASSOCIATION; CARCINOMA; GUIDELINES; OUTCOMES;
D O I
10.1016/j.ajur.2023.04.007
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective: Non-muscle-invasive bladder cancer (NMIBC) remains a common challenge in uro-oncology with conflicting reports on recurrence risk. This study aimed to elucidate the recurrence rate of NMIBC in the Cancer Clinic of Shahid Beheshti Hospital in Iran and to investigate related parameters affecting recurrence risk. Methods: The data of 143 patients with NMIBC, who underwent treatment between January 2017 and January 2020 and were followed up from the initial transurethral resection of bladder tumor until November 30, 2020 in our institution, were retrospectively assessed. The Cox regression analysis and Kaplan-Meier plot of recurrence-free survival were used to determine independent contributing factors for tumor recurrence. Results: Among patients with NMIBC, 83.9% were male, and 16.1% were female, with a mean age of 64.4 (standard deviation [SD] 12.9) years. During the follow-up, 71 (49.7%) patients showed tumor recurrence, with a mean recurrence time of 11.5 (SD 6.9) months. In the Chi-square test or Fisher's exact test, the age (>= 65 years) (p=0.037), obesity (body mass index >= 30 kg/m(2)) (p=0.004), no diabetes mellitus (p=0.005), smoking (current or former smoker) (p=0.001), immediate perfusion therapy (p=0.035), number of tumors (>3) (p<0.001), and tumor stage (Ta, T1, and Tis) (p=0.001) had independent significant effects on the recurrence of NMIBC. The multivariate Cox regression analysis indicated that preoperative obesity (hazards ratio [HR] 7.90; 95% confidential interval [CI] 4.01-15.55; p<0.001), current or former smoking (HR 1.85; 95% CI 1.07-3.20; p=0.027), and a high-grade tumor (HR 4.03; 95% CI 1.59-10.25; p=0.003) were significant predictors of tumor recurrence. The Kaplan-Meier plot of recurrence-free survival showed that obesity (log-rank p<0.001), current or former smoking (log-rank p=0.001), and a high-grade tumor (log-rank p=0.006) were associated with a shorter time interval until the first tumor recurrence. Conclusion: The study found a high recurrence rate of NMIBC in Iran from January 2017 to January 2020, with the obesity, smoking history, and the high-grade tumor as contributing factors.
引用
收藏
页码:625 / 632
页数:8
相关论文
共 47 条
[1]   Superficial bladder tumours: analysis of prognostic factors and construction of a predictive index [J].
Ali-El-Dein, B ;
Sarhan, O ;
Hinev, A ;
Ibrahiem, EHI ;
Nabeeh, A ;
Ghoneim, MA .
BJU INTERNATIONAL, 2003, 92 (04) :393-399
[2]   European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ) [J].
Babjuk, Marko ;
Burger, Maximilian ;
Capoun, Otakar ;
Cohen, Daniel ;
Comperat, Eva M. ;
Escrig, Jose L. Dominguez ;
Gontero, Paolo ;
Liedberg, Fredrik ;
Masson-Lecomte, Alexandra ;
Mostafid, A. Hugh ;
Palou, Joan ;
van Rhijn, Bas W. G. ;
Roupret, Morgan ;
Shariat, Shahrokh F. ;
Seisen, Thomas ;
Soukup, Viktor ;
Sylvester, Richard J. .
EUROPEAN UROLOGY, 2022, 81 (01) :75-94
[3]   European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-2019 Update [J].
Babjuk, Marko ;
Burger, Maximilian ;
Comperat, Eva M. ;
Gontero, Paolo ;
Mostafid, A. Hugh ;
Palou, Joan ;
van Rhijn, Bas W. G. ;
Roupret, Morgan ;
Shariat, Shahrokh F. ;
Sylvester, Richard ;
Zigeuner, Richard ;
Capoun, Otakar ;
Cohen, Daniel ;
Dominguez Escrig, Jose Luis ;
Hernandez, Virginia ;
Peyronnet, Benoit ;
Seisen, Thomas ;
Soukup, Viktor .
EUROPEAN UROLOGY, 2019, 76 (05) :639-657
[4]  
Bachir BG, 2012, EXPERT REV ANTICANC, V12, P1499, DOI [10.1586/era.12.140, 10.1586/ERA.12.140]
[5]   Epidemiology and Risk Factors of Urothelial Bladder Cancer [J].
Burger, Maximilian ;
Catto, James W. F. ;
Dalbagni, Guido ;
Grossman, H. Barton ;
Herr, Harry ;
Karakiewicz, Pierre ;
Kassouf, Wassim ;
Kiemeney, Lambertus A. ;
La Vecchia, Carlo ;
Shariat, Shahrokh ;
Lotan, Yair .
EUROPEAN UROLOGY, 2013, 63 (02) :234-241
[6]   Urinary Biomarkers for Diagnosis of Bladder Cancer A Systematic Review and Meta-analysis [J].
Chou, Roger ;
Gore, John L. ;
Buckley, David ;
Fu, Rongwei ;
Gustafson, Katie ;
Griffin, Jessica C. ;
Grusing, Sara ;
Selph, Shelley .
ANNALS OF INTERNAL MEDICINE, 2015, 163 (12) :922-+
[7]   Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG [J].
Contieri, Roberto ;
Hurle, Rodolfo ;
Paciotti, Marco ;
Casale, Paolo ;
Saita, Alberto ;
Porpiglia, Francesco ;
Fiori, Cristian ;
Barone, Biagio ;
Crocetto, Felice ;
Lucarelli, Giuseppe ;
Busetto, Gian M. ;
Del Giudice, Francesco ;
Maggi, Martina ;
Cantiello, Francesco ;
Damiano, Rocco ;
Borghesi, Marco ;
Bove, Pierluigi ;
Bertolo, Riccardo ;
Papalia, Rocco ;
Mari, Andrea ;
Luzzago, Stefano ;
Mistretta, Francesco A. ;
Soria, Francesco ;
Gontero, Paolo ;
Marchioni, Michele ;
La Civita, Evelina ;
Terracciano, Daniela ;
Russo, Giorgio I. ;
Schips, Luigi ;
Perdona, Sisto ;
Mirone, Vincenzo ;
Tataru, Octavian S. ;
Musi, Gennaro ;
Vartolomei, Mihai D. ;
Autorino, Riccardo ;
Montanari, Emanuele ;
De Cobelli, Ottavio ;
Ferro, Matteo .
MINERVA UROLOGY AND NEPHROLOGY, 2023, 75 (02) :180-187
[8]   No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression [J].
Evers, Jelle ;
Grotenhuis, Anne J. ;
Aben, Katja K. H. ;
Kiemeney, Lambertus A. L. M. ;
Vrieling, Alina .
PLOS ONE, 2020, 15 (03)
[9]   Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer [J].
Ferro, Matteo ;
Barone, Biagio ;
Crocetto, Felice ;
Lucarelli, Giuseppe ;
Busetto, Gian Maria ;
Del Giudice, Francesco ;
Maggi, Martina ;
Crocerossa, Fabio ;
Cantiello, Francesco ;
Damiano, Rocco ;
Borghesi, Marco ;
Bove, Pier Luigi ;
Papalia, Rocco ;
Mari, Andrea ;
Luzzago, Stefano ;
Soria, Francesco ;
Marchioni, Michele ;
La Civita, Evelina ;
Terracciano, Daniela ;
Mistretta, Francesco Alessandro ;
Piccinelli, Mattia ;
Marmiroli, Andrea ;
Russo, Giorgio Ivan ;
Schips, Luigi ;
Hurle, Rodolfo ;
Contieri, Roberto ;
Perdona, Sisto ;
Del Prete, Paola ;
Mirone, Vincenzo ;
Tataru, Octavian Sabin ;
Musi, Gennaro ;
Montanari, Emanuele ;
de Cobelli, Ottavio ;
Vartolomei, Mihai Dorin .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (11) :490.e13-490.e20
[10]   Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicenter study [J].
Ferro, Matteo ;
Marchioni, Michele ;
Lucarelli, Giuseppe ;
Vartolomei, Mihai D. ;
Soria, Francesco ;
Terracciano, Daniela ;
Mistretta, Francesco A. ;
Luzzago, Stefano ;
Buonerba, Carlo ;
Cantiello, Francesco ;
Mari, Andrea ;
Minervini, Andrea ;
Veccia, Alessandro ;
Antonelli, Alessandro ;
Musi, Gennaro ;
Hurle, Rodolfo ;
Busetto, Gian M. ;
Del Giudice, Francesco ;
Chung, Benjamin, I ;
Berardinelli, Francesco ;
Perdona, Sisto ;
Del Prete, Paola ;
Mirone, Vincenzo ;
Borghesi, Marco ;
Porreca, Angelo ;
Bove, Pierluigi ;
Autorino, Riccardo ;
Crisan, Nicolae ;
Abu Farhan, Abdal R. ;
Battaglia, Michele ;
Ditonno, Pasquale ;
Russo, Giorgio, I ;
Muto, Matteo ;
Damiano, Rocco ;
Manfredi, Matteo ;
Porpiglia, Francesco ;
De Cobelli, Ottavio ;
Schips, Luigi .
MINERVA UROLOGY AND NEPHROLOGY, 2021, 73 (06) :796-802